Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole plus leuprorelin in girls with early or precocious puberty and compromised growth potential
ISRCTN11469487Phase 2Completed
- Sponsor
- Attikon University Hospital
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of anastrozole and leuprolide in precocious puberty (4 arms), sponsored by Attikon University Hospital. Primary endpoints: Predicted adult height, Height velocity and 3 more. Started Jan 2008; status: completed.
02
Drugs
anastrozoleleuprolide
03
Conditions
precocious puberty
Beyond the preview
Go deeper on ISRCTN11469487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11469487.